Weight loss and hormone combo may make endometrial cancer surgery safer for obese women
NCT ID NCT07462663
First seen Mar 10, 2026 · Last updated May 25, 2026 · Updated 13 times
Summary
This study tests a program for women with severe obesity (BMI 40+) and early-stage endometrial cancer. The program includes weight loss medication, a hormone-releasing IUD, diet, and exercise to help them lose weight and improve health before surgery. The goal is to see if this approach makes surgery safer and keeps the cancer from growing. About 82 women will take part over 28-54 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.